FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

Q3 2025 Earnings Call Transcript November 14, 2025 P3 Health Partners Inc. misses on earnings expectations. Reported EPS is $ ...

Q3 2025 Earnings Call Transcript November 13, 2025 Operator: You all sites on hold. We appreciate your patience, and please ...

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

Net order intake was approximately $19,000,000 and we achieved a positive gross margin of 15%. While this margin result may ...

Participation in the reactor pilot program gives us access to a Department of Energy authorization pathway aligning our ...

Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsJay Short - Co-Founder, CEO & ChairmanSheri Lydick - ...

Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30404 EPS, expectations were $-0.04. Operator ...

Sera Prognostics, Inc. ( SERA) Q3 2025 Earnings Call November 13, 2025 5:00 PM EST Good afternoon, and welcome to the Sera Prognostics Conference Call to review third quarter fiscal year 2025 results.

Operator: Greetings, and welcome to the Mastech Digital, Inc. Third Quarter 2025 Earnings Conference Call. [Operator ...

CLEVELAND, Ohio — Browns head coach Kevin Stefanski took questions from reporters on Wednesday with regard to preparing for ...

A sharp rise in students without middle school-level math skills is raising alarms among educators and policymakers.